RN-0361

N/A

Report date: 2025/11/04 10:59:13
NME

Base Information

Drug NameRN-0361
Drug Alias NameRN0361RN-0361
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApolipoprotein C-III inhibitorsRNA interference
TargetsApolipoprotein C-III
Therapy Area/IndicationsHypertriglyceridemiaHyperlipoproteinemia Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIkaria Bioscience Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIkaria Bioscience Pty LtdRona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaHyperlipoproteinemia Type I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A